ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Clinical practice"

  • Abstract Number: 109 • 2020 Pediatric Rheumatology Symposium

    Incidence, Contributing Factors, and Impact of Diagnostic Delay in Juvenile Idiopathic Arthritis: Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry

    Mei-Sing Ong1, Gordon Schiff 2 and Marc Natter 3 for the CARRA investigators, 1Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, 2Harvard Medical School, Boston, 3Boston Children's Hospital, Boston

    Background/Purpose: While early treatment of patients with newly diagnosed juvenile idiopathic arthritis (JIA) is an area of active study, delayed diagnosis of JIA is poorly…
  • Abstract Number: 191 • 2020 Pediatric Rheumatology Symposium

    Utilization of Telemedicine in Pediatric Rheumatologic Care

    Rajdeep Pooni1 and Tzielan Lee 1, 1Stanford Children's, Palo Alto

    Background/Purpose: Telemedicine has the potential for improving access to care, particularly for pediatric patients with complex needs in remote or rural locations. Previous studies have…
  • Abstract Number: 2461 • 2019 ACR/ARP Annual Meeting

    Clinical Presentation and Treatment of Oligoarticular Psoriatic Arthritis in Canada: High Frequency of Smaller Joint Involvement

    Alfred Cividino1, Denise Nicholson 2, Sherif Guindi 2, Jennifer Jelley 2, Anne-Julie Gaudreau 2 and Dafna Gladman 3, 1McMaster University's Faculty of Health Sciences, Hamilton, ON, Canada, 2Celgene Corporation, Summit, NJ, 3University of Toronto, Toronto, ON, Canada

    Background/Purpose: Oligoarticular disease in patients with psoriatic arthritis (PsA) is often underdiagnosed and undertreated. The goal of this study is to understand and identify current…
  • Abstract Number: 2524 • 2019 ACR/ARP Annual Meeting

    24-Month Outcomes Associated with Belimumab in Black/African-American Patients with Systemic Lupus Erythematosus in a Clinical Practice Setting in the United States

    Christopher Collins 1, Gail Kerr 2, Joan Von Feldt 3, Bernie Rubin 4, Arie Katz 3, Vanessa Castellano 5, Jake Chung 4 and Christopher Bell5, 1MedStar Washington Hospital Center, Department of Rheumatology, Washington, DC, 2Washington DC VA Medical Center, Georgetown and Howard Universities, Washington DC, DC, 3GSK, Philadelphia, PA, 4GSK, Phildelphia, PA, 5GSK, Research Triangle Park, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by diverse clinical manifestations and organ damage accrual. Black/African-American (B/AA) race is associated with…
  • Abstract Number: 2720 • 2019 ACR/ARP Annual Meeting

    Implementation of an Evidence-based Transition Clinic in a Pediatric Rheumatology Academic Institution

    Rebecca Overbury1, John Bohnsack 2, CJ Inman 3, Sara Stern 3, Karen James 3, Daniel Clegg 3, Tracy Frech 4 and Aimee Hersh 3, 1Assisstant Professor, University of Utah, Salt Lake City, UT, 2University of Utah School of Medicine, Salt Lake City, UT, 3University of Utah, Salt Lake City, UT, 4Division of Rheumatology, University of Utah and Salt Lake VAMC, Salt Lake City, UT

    Background/Purpose: Transition from pediatric to adult rheumatology care is more likely to be successful if a transition program is in place. Previously successful interventions to…
  • Abstract Number: 2796 • 2019 ACR/ARP Annual Meeting

    The Association Between Omega-3 Supplementation and Disease Activity in a Rheumatoid Arthritis (RA) Observational Cohort

    Adel Andemeskel1, Vivi Feathers 1, Christine Iannaccone 1, Jing Cui 1 and Nancy Shadick 1, 1Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Omega-3 supplementation is one of a few complementary and alternative medicine (CAM) therapies that has shown promise in improving RA symptoms through small, randomized…
  • Abstract Number: 302 • 2019 ACR/ARP Annual Meeting

    Clinical Impact of a Rheumatology Musculoskeletal Ultrasound Clinic at a U.S. Academic Center

    Sarah Chung1, Katherine Wysham 2, Elizabeth Jernberg 3, Ingeborg Sacksen 3, Scott Pollock 1 and Alison Bays 1, 1University of Washington Division of Rheumatology, Seattle, WA, 2Veterans Health Administration Puget Sound, Seattle WA, Seattle, 3University of Washington Division of Rheumatology, Seattle

    Background/Purpose: Routine use of musculoskeletal ultrasound (MSK-US) to aid in clinical decision-making for rheumatology patients is less common in the United States than in Europe,…
  • Abstract Number: 654 • 2019 ACR/ARP Annual Meeting

    Applying Systemic Lupus International Collaborating Clinics (SLICC) and Provisional ACR/EULAR Systemic Lupus Erythematosus Classification Criteria in a Cohort of Patients with Undifferentiated Connective Tissue Disease

    Kyle Drehmel1, Alan Erickson 1, Bryant England 2 and Michelene Hearth-Holmes 1, 1University of Nebraska Medical Center, Omaha, NE, 2VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha

    Background/Purpose: Undifferentiated Connective Tissue Disease (UCTD) describes the clinical scenario where a patient demonstrates characteristics of a connective tissue disease but does not meet criteria…
  • Abstract Number: 1530 • 2019 ACR/ARP Annual Meeting

    Real World Effectiveness of Secukinumab in Patients with Ankylosing Spondylitis: Findings from a Recent Cross Sectional Survey of Rheumatologists and Patients in Europe

    Uta Kiltz 1, Elizabeth Holdsworth2, Haijun Tian 3, Nicola Booth 4, Papa Anthony 5, Lina Helsche 6, Dorothy Keininger 6 and Philip G Conaghan 7, 1Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, 2Adelphi Real World, Manchester, England, United Kingdom, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Adelphi Real World, Bollington, United Kingdom, 5Adelphi Real World, Macclesfield, England, United Kingdom, 6Novartis Pharma AG, Basel, Basel-Landschaft, Switzerland, 7Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom

    Background/Purpose: Ankylosing spondylitis (AS) can lead to reduced physical functioning and quality of life.  Secukinumab has demonstrated clinical benefits in AS patients in clinical trials1-2.…
  • Abstract Number: 2155 • 2018 ACR/ARHP Annual Meeting

    Diagnosis of Systemic Sclerosis in the United Kingdom: An Observational Study Using the Clinical Practice Research Datalink

    Alicia Gayle1, Nils Schoof2, Margarida Alves2, Deborah Clarke3, Chris Poole1, Christina Raabe2, Prithwiraj Das1 and Toby Maher4, 1Boehringer Ingelheim Ltd., Bracknell, United Kingdom, 2Boehringer Ingelheim International GmbH, Ingelheim, Germany, 3Department of Medical Affairs, Boehringer Ingelheim Ltd., Bracknell, United Kingdom, 4University College London and Royal Brompton Hospital, London, United Kingdom

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease that is characterised by fibroblast dysfunction and excess extracellular matrix deposition that leads to skin thickening and…
  • Abstract Number: 2348 • 2018 ACR/ARHP Annual Meeting

    Prescriber Attitudes and Beliefs about Triple Therapy for Patients with Rheumatoid Arthritis: Knowledge Exchange in Internet Forums and Social Media

    Maria A. Lopez-Olivo1, Jude K. A. des Bordes1, Gregory Pratt2 and Maria Suarez-Almazor1, 1Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: Several forums on the internet serve as repositories of personal experiences and exchange of health information. Online discussions among healthcare providers about management of…
  • Abstract Number: 2516 • 2018 ACR/ARHP Annual Meeting

    Long-Term Maintenance of Response in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol

    Alain Saraux1, René-Marc Flipo2, Francis Fagnani3, Gabrielle Cukierman4, Isabelle Bru4, Jean-Michel Joubert4, Jan-Christof Schuller5, Jacques Massol6 and Bernard Combe7, 1CHU La Cavale Blanche, Brest, France, 2Hôpital Roger Salengro, Lille, France, 3Cemka-Eval, Bourg-la-Reine, France, 4UCB Pharma, Colombes, France, 5UCB Pharma, Brussels, Belgium, 6CHU de Besançon, Besançon, France, 7CHU Lapeyronie, Montpellier, France

    Background/Purpose: The safety and efficacy of certolizumab pegol (CZP) for treating patients (pts) with rheumatoid arthritis (RA) are well-established in a clinical trial setting.1,2 However,…
  • Abstract Number: 2589 • 2018 ACR/ARHP Annual Meeting

    Clinical Characteristics and Treatment Profile of Patients with Psoriatic Arthritis Who Initiated Secukinumab and Other Biologics: Results from the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry

    Alexis Ogdie1, Mei Liu2, Sabrina Rebello3, Meghan Glynn2, Peter Hur4 and Philip J. Mease5, 1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 2Corrona, LLC, Waltham, MA, 3Corrona, LLC, Southborough, MA, 4Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, East Hanover, NJ, 5Swedish Medical Center and University of Washington, Seattle, WA

    Background/Purpose: Few real-world studies have characterized patients with psoriatic arthritis (PsA) who initiate secukinumab. This study described characteristics of patients who initiated secukinumab and other…
  • Abstract Number: 2609 • 2018 ACR/ARHP Annual Meeting

    Survival of Disease-Modifying Drugs in Patients with Recent Diagnosis of Psoriatic Arthritis in Daily Clinical Practice

    Dalifer Freites Núñez1, Zulema Rosales Rosado1,2, Judit Font Urgelles2, Isabel Hernández-Rodríguez2, Leticia Leon1, Gloria Candelas Rodriguez2, Luis Rodriguez-Rodriguez1, Benjamín Fernández-Gutiérrez1,2, Juan A Jover Jover2 and Lydia A Alcazar1, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose: Psoriatic arthritis (PsA) is a chronic inflammatory disease that benefits from DMARDs, in this regard knowing more about these therapies is a great step…
  • Abstract Number: 2633 • 2018 ACR/ARHP Annual Meeting

    Disease Activity, Organ Damage and Patient-Reported Outcome Measures in Swedish Patients with Recent-Onset SLE

    Rebecca Heijke1, Mathilda Björk1, Martina Frodlund1, Laura McDonald2, Evo Alemao3 and Christopher Sjöwall1, 1Linköping University, Linköping, Sweden, 2Bristol-Myers Squibb, Uxbridge, United Kingdom, 3Bristol-Myers Squibb, Princeton, NJ

    Background/Purpose: Patient (pt)-reported outcome measures (PROMs) are important to inform shared decision-making between pts with SLE and physicians.1 Established measures of disease activity and organ…
  • 1
  • 2
  • 3
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.